Literature DB >> 8986665

Limb salvage for neoplasms of the shoulder girdle. Intermediate reconstructive and functional results.

M I O'Connor1, F H Sim, E Y Chao.   

Abstract

The intermediate functional results were assessed for fifty-seven patients who had had a limb-salvage procedure for treatment of a tumor of the shoulder girdle region at our institution from 1980 through 1990. Fifty-three patients had a malignant bone tumor (a sarcoma) and four had an extensive giant-cell tumor. The resections were classified according to the system of the Musculoskeletal Tumor Society. A variety of reconstructive procedures were performed after resection of the tumor, with the choice of procedure depending on the type of resection and the needs of the patient. The functional results were described and graded quantitatively according to the functional rating system of the Musculoskeletal Tumor Society. The average duration of follow-up was 5.3 years (median, 4.6 years) for the forty-seven patients who were still alive at the time of the latest follow-up examination. Eight patients died of disease and two others died of unrelated malignant tumors an average of 1.8 years postoperatively. The resection of the tumor was classified as wide in forty of the fifty-three patients who had a sarcoma and as marginal in thirteen; four patients had local recurrence (two, after a wide resection, and two, after a marginal resection). One of the four patients who had a giant-cell tumor had local recurrence. The functional results were related to the type of resection and the method of skeletal reconstruction. After resection of the entire scapula and the proximal aspect of the humerus, reconstruction with a spacer frequently resulted in asymptomatic superior subluxation of the implant and poor function of the shoulder. After extra-articular resection of the glenoid cavity and the proximal aspect of the humerus with loss of the abductor mechanism, osseous arthrodesis resulted in good function that was superior to that found after reconstruction with a spacer or a proximal humeral replacement prosthesis. Our preferred method to achieve fusion was insertion of an intercalary allograft and a vascularized fibular graft. However, the allograft fractured in three of four patients in whom primary fusion had been obtained with this technique. An osteoarticular allograft inserted after intra-articular resection of the proximal aspect of the humerus and preservation of the abductor mechanism provided good function that was superior to that found after reconstruction with a proximal humeral replacement prosthesis, which produced symptomatic instability that led to a secondary arthrodesis in some patients. However, subchondral fracture and collapse of the osteoarticular allograft occurred in four of eight patients by the time of the latest follow-up examination. The results of all methods of reconstruction were satisfactory with regard to pain, emotional acceptance, and manual dexterity. We believe that the use of a method of reconstruction that is appropriate with regard to the needs of the patient and preoperative counseling regarding the expected functional level and restrictions of activity are critical for a high level of postoperative satisfaction.

Entities:  

Mesh:

Year:  1996        PMID: 8986665     DOI: 10.2106/00004623-199612000-00011

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  30 in total

1.  Limb salvage for malignant bone and soft-tissue tumours of the shoulder girdle.

Authors:  Hirofumi Taira; Seiji Yoshida; Mitsuhiro Takasita; Hiroshi Tsumura; Takehiko Torisu
Journal:  Int Orthop       Date:  2003-02-08       Impact factor: 3.075

2.  [Allografts in reconstruction of osseous defects in primary malignant bone tumors].

Authors:  P Wuisman; F Gohlke; A Witlox
Journal:  Orthopade       Date:  2003-11       Impact factor: 1.087

3.  Reconstruction with scapular hemiarthroplasty endoprosthesis after scapulectomy for malignant tumour.

Authors:  Li Min; Yong Zhou; Fan Tang; Wenli Zhang; Yi Luo; Hong Duan; Chongqi Tu
Journal:  Int Orthop       Date:  2017-03-06       Impact factor: 3.075

4.  CORR Insights®: Do Early Results of Proximal Humeral Allograft-Prosthetic Composite Reconstructions Persist at 5-year Followup?

Authors:  Matthew T Houdek
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

Review 5.  Complex surgery for locally advanced bone and soft tissue sarcomas of the shoulder girdle.

Authors:  Jan Lesenský; Andreas F Mavrogenis; Vasilios G Igoumenou; Zdenek Matejovsky; Karel Nemec; Panayiotis J Papagelopoulos; Nicola Fabbri
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-06-29

6.  Does total humeral endoprosthetic replacement provide reliable reconstruction with preservation of a useful extremity?

Authors:  Hazem Wafa; Krishna Reddy; Robert Grimer; Adesegun Abudu; Lee Jeys; Simon Carter; Roger Tillman
Journal:  Clin Orthop Relat Res       Date:  2015-03       Impact factor: 4.176

Review 7.  Outcome after reconstruction of the proximal humerus for tumor resection: a systematic review.

Authors:  Teun Teunis; Sjoerd P F T Nota; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón
Journal:  Clin Orthop Relat Res       Date:  2014-01-28       Impact factor: 4.176

8.  Conservative treatment of Campanacci grade III proximal humerus giant cell tumors.

Authors:  Richard D Lackman; Eileen A Crawford; Joseph J King; Christian M Ogilvie
Journal:  Clin Orthop Relat Res       Date:  2008-11-06       Impact factor: 4.176

9.  Proximal humerus reconstructions for tumors.

Authors:  Benjamin K Potter; Sheila C Adams; J David Pitcher; Theodore I Malinin; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2008-09-27       Impact factor: 4.176

10.  Primary malignant tumours of the scapula--a review of 29 cases.

Authors:  Stephan E Puchner; Joannis Panotopoulos; Rudolf Puchner; Reinhard Schuh; Reinhard Windhager; Philipp T Funovics
Journal:  Int Orthop       Date:  2014-06-25       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.